pvdl2 slf22
Name
slf12
Label
First Generation Sulfonylureas (SHHS2)
Description

Participant taking FIRST GENERATION SULFONYLUREAS within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
  • 8: Don't know
Type
choices
Tags
diabetes SLF12
First Generation Sulfonylureas (SHHS2) vs SHHS Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,612 -
Yes - - 8 -
Don't know - - - -
Unknown - - 460 -
First Generation Sulfonylureas (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 176 647 1,148 1,052 549 40 3,612
Yes - - - 4 4 - 8
Don't know - - - - - - -
Unknown 8 60 173 144 71 4 460
First Generation Sulfonylureas (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,656 1,956 3,612
Yes 5 3 8
Don't know - - -
Unknown 200 260 460
First Generation Sulfonylureas (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,155 241 216 3,612
Yes 7 1 - 8
Don't know - - - -
Unknown 425 14 21 460